A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217). - Capdevila, Jaume; Pubul, Virginia; Anido, Urbano; Walter, Thomas; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Garcia-Carbonero, Rocio; San-Roman-Gil, Maria; Llana, Belen; Jimenez-Fonseca, Paula; Benavent Viñuales, Marta; Ansquer, Catherine; et al. (BMC Cancer, 2025)